GLANATEC Trademark

Trademark Overview

On Wednesday, August 31, 2022, a trademark application was filed for GLANATEC with the United States Patent and Trademark Office. The USPTO has given the GLANATEC trademark a serial number of 79352021. The federal status of this trademark filing is REGISTERED as of Tuesday, March 5, 2024. This trademark is owned by KOWA COMPANY, LTD.. The GLANATEC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of glaucoma and ocular hypertension; pharmaceutical preparations for the treatment of corneal endothelial disorder; sanitary preparations for medical use
glanatec

General Information

Serial Number79352021
Word MarkGLANATEC
Filing DateWednesday, August 31, 2022
Status700 - REGISTERED
Status DateTuesday, March 5, 2024
Registration Number7318223
Registration DateTuesday, March 5, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of glaucoma and ocular hypertension; pharmaceutical preparations for the treatment of corneal endothelial disorder; sanitary preparations for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKOWA COMPANY, LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameKOWA COMPANY, LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameKOWA COMPANY, LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Saturday, November 26, 2022ASSIGNED TO EXAMINER
Thursday, October 6, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, October 17, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, October 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 22, 2022APPLICATION FILING RECEIPT MAILED
Sunday, November 27, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 25, 2023REFUSAL PROCESSED BY MPU
Monday, November 28, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 20, 2023REFUSAL PROCESSED BY IB
Tuesday, March 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 10, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 27, 2023SUSPENSION LETTER WRITTEN
Monday, March 27, 2023LETTER OF SUSPENSION E-MAILED
Monday, March 27, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 29, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2024NOTIFICATION PROCESSED BY IB

Related Keywords

glanatec preparations pharmaceutical treatment disorder medical endothelial sanitary hypertension glaucoma ocular